Sorrento OK'd For Alternative $110M Ch. 11 Stock Sale

By Emily Lever · September 12, 2023, 10:30 PM EDT

Bankrupt drug developer Sorrento Therapeutics received a Texas court's approval Tuesday for subsidiary Scilex Holding Co. to buy its own stock back from its parent for $110 million after the original...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

California biopharmaceutical firm Sorrento Therapeutics Inc., filed for Chapter 11 protection with about $135 million in debt, in the face of a $175 million arbitration award.

Case Number

4:23-bk-90085

Judge

Christopher M. Lopez

Venue

U.S. Bankruptcy Court for the Southern District of Texas

Capital Structure

View Full Scorecard

Related Sections

Case Information

Case Title

Sorrento Therapeutics, Inc.

Case Number

4:23-bk-90085

Court

Texas Southern

Nature of Suit

Date Filed

February 13, 2023

Recent Articles By Emily